⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
KMDA News
Kamada Ltd
Kamada Reports Record-High First Half and Second Quarter 2026 Financial Results, Representing Double-Digit Profitable Growth and the Strongest in Kamada's History; Affirms 2026 Annual Guidance
globenewswire.com
KMDA
Kamada Announces Planned Transition of Chief Financial Officer
globenewswire.com
KMDA
Kamada to Announce Second Quarter and First Half Ended June 30, 2026 Financial Results on August 12, 2026
globenewswire.com
KMDA
Kamada Announces a Three-Year $50 Million Sales Agreement to Supply Plasma to a Leading Biopharmaceutical Company focused on Plasma-derived Therapies
globenewswire.com
KMDA
Kamada Highlights CYTOGAM® Study Results Presented at the 2026 ISHLT Annual Meeting
globenewswire.com
KMDA
Kamada Announces FDA Approval of its New In-House Rabies Virus Neutralization Testing Laboratory
globenewswire.com
KMDA
Kamada Reports First Quarter 2026 Financial Results and Affirms 2026 Annual Guidance; Expecting Significantly Stronger Remainder of the Year
globenewswire.com
KMDA
Kamada to Announce First Quarter 2026 Financial Results on May 13, 2026
globenewswire.com
KMDA
VariZIG Market Research Report 2026: Epidemiology, Pipeline Analysis, Insights & Forecasts 2020-2035
globenewswire.com
KMDA
Kamada Updates on Withholding Tax Procedures on Previously Announced Cash Dividend to Shareholders
globenewswire.com
KMDA